BHC appears attractive to hedge funds

PARAGRAPH 1 --- What happened: Hedge funds are increasingly bullish on certain tech and healthcare stocks. Meta Platforms (META) is favored by 90% of analysts, with a consensus price target implying 50% upside. CoStar Group (CSGP), a PropTech stock, is also highly favored by hedge funds, with BITG maintaining a Buy rating post-Q4 results. Meanwhile, Bausch Health (BHC), a small-cap drug manufacturer, is attractive to hedge funds, with Barclays maintaining an Equal Weight rating.

PARAGRAPH 2 --- Market impact: This narrative is driving interest in tech and healthcare stocks, particularly those with strong fundamentals and positive analyst sentiment. Meta's bullish outlook is pushing its stock price higher, while CoStar's favorability is buoying PropTech stocks. Bausch Health's attractiveness is influencing small-cap drug manufacturing stocks.

PARAGRAPH 3 --- What to watch next: Meta's next earnings report on July 26 will provide insights into its 2026 growth prospects. CoStar's upcoming Q1 results on May 4 will offer a clearer picture of its current performance. For Bausch Health, investors should watch its Q1 results on May 10, which may reveal its progress in turning around its business.